At CTS, we understand the impact converting to the Ortho viral marker platform has on your operations. As we get closer to our implementation date of January 11, 2021 we are committed to providing you information as it becomes available.
Package inserts for the new assays are now available. You can review them on the Communications page by clicking this link: Communications,
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...